Gut microbiota as a regulator of energy homeostasis and ectopic fat deposition: mechanisms and implications for metabolic disorders

被引:146
|
作者
Musso, Giovanni [1 ]
Gambino, Roberto [2 ]
Cassader, Maurizio [2 ]
机构
[1] Gradenigo Hosp, I-10132 Turin, Italy
[2] Univ Turin, Dept Internal Med, I-10124 Turin, Italy
关键词
endotoxin; energy homeostasis; microbiota; NAFLD; obesity; DIET-INDUCED OBESITY; NONALCOHOLIC STEATOHEPATITIS; LIVER-DISEASE; HEPATIC STEATOSIS; GLUCOSE-TOLERANCE; LINOLEIC-ACID; MICE; ENDOTOXEMIA; PATHOGENESIS; BIFIDOBACTERIA;
D O I
10.1097/MOL.0b013e3283347ebb
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Purpose of review To examine the role of gut microbiota in the regulation of host energy homeostasis and its role in the pathogenesis of obesity, diabetes and nonalcoholic fatty liver disease (NAFLD) Recent findings Experimental models highlight several mechanisms connecting gut microbiota to host energy metabolism: increased energy harvesting from the diet, regulation of appetite through gut peptide, secretion, regulation of tissue-free fatty acid composition and uptake, storage and oxidation, modulation of intestinal barrier by glucagon-like peptide-2 secretion, activation of innate immunity and hepatic fibrogenesis through the lipopolysaccharide (LPS) toll-like receptor-4 axis. Gut microbiota manipulation through antibiotics, prebiotics and probiotics yields encouraging results for the treatment of obesity, diabetes and NAFLD in animal models, but data in humans are currently scarce. Summary Gut microbiota manipulation yielded encouraging results for the treatment of different metabolic disorders in experimental models. However, changing intestinal microbiota may be more difficult in free-living individuals compared to standardized laboratory models, and its long-term consequences are unknown. To safely and effectively change human gut microflora, future research should highlight the complex hormonal, immunomodulatory and metabolic mechanisms underlying microbiota host interactions in different tissues and candidate treatments should be evaluated in well designed trials with patient-oriented end-points.
引用
收藏
页码:76 / 83
页数:8
相关论文
共 50 条
  • [1] Thermogenic Brown Fat in Humans: Implications in Energy Homeostasis, Obesity and Metabolic Disorders
    Saito, Masayuki
    Okamatsu-Ogura, Yuko
    WORLD JOURNAL OF MENS HEALTH, 2023, 41 (03): : 489 - 507
  • [2] Gut Microbiota and Metabolic Disorders
    Hur, Kyu Yeon
    Lee, Myung-Shik
    DIABETES & METABOLISM JOURNAL, 2015, 39 (03) : 198 - 203
  • [3] Interactions of dietary fat with the gut microbiota: Evaluation of mechanisms and metabolic consequences
    Mokkala, Kati
    Houttu, Noora
    Cansev, Tugce
    Laitinen, Kirsi
    CLINICAL NUTRITION, 2020, 39 (04) : 994 - 1018
  • [4] Ectopic fat deposition and lipotoxic disorders
    Shimabukuro, Michio
    Masuzaki, Hiroaki
    ENDOCRINE JOURNAL, 2010, 57 : S316 - S316
  • [5] Gut Microbiota and Energy Homeostasis in Fish
    Butt, Robyn Lisa
    Volkoff, Helene
    FRONTIERS IN ENDOCRINOLOGY, 2019, 10
  • [6] The gut microbiota: a key regulator of metabolic diseases
    Yang, Jin-Young
    Kweon, Mi-Na
    BMB REPORTS, 2016, 49 (10) : 536 - 541
  • [7] Eating Disorders and the Intestinal Microbiota: Mechanisms of Energy Homeostasis and Behavioral Influence
    Elaine M. Glenny
    Emily C. Bulik-Sullivan
    Quyen Tang
    Cynthia M. Bulik
    Ian M. Carroll
    Current Psychiatry Reports, 2017, 19
  • [8] Eating Disorders and the Intestinal Microbiota: Mechanisms of Energy Homeostasis and Behavioral Influence
    Glenny, Elaine M.
    Bulik-Sullivan, Emily C.
    Tang, Quyen
    Bulik, Cynthia M.
    Carroll, Ian M.
    CURRENT PSYCHIATRY REPORTS, 2017, 19 (08)
  • [9] Gut microbiota in obesity and metabolic disorders
    Sanz, Yolanda
    Santacruz, Arlette
    Gauffin, Paola
    PROCEEDINGS OF THE NUTRITION SOCIETY, 2010, 69 (03) : 434 - 441
  • [10] The molecular mechanisms underlying gut microbiota-miRNA interaction in metabolic disorders
    Prukpitikul, P.
    Sirivarasai, J.
    Sutjarit, N.
    BENEFICIAL MICROBES, 2024, 15 (01) : 83 - 96